Proffitt & Goodson’s Geron GERN Stock Holding History

Proffitt & Goodson’s Portfolio GERN Stock Details GERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-600	Closed	-$1K	–	252
2022 Q2	$1K	Buy	+600	New	+$848	﹤0.01%	254

Other funds holding GERN

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Proffitt & Goodson's GERN Position: Q3 2022 in Review

Proffitt & Goodson sold out of Geron (GERN) in Q3 2022, closing a stake of 600 shares — an estimated $1K sold.

Proffitt & Goodson first reported a position in GERN in Q2 2022 and held it in 1 quarter. The position peaked at $1K in Q2 2022. 179 funds tracked by Wall St. Rank hold GERN as of Q3 2022.

Proffitt & Goodson reported no remaining Geron position as of Q3 2022 after selling out during the quarter.
Proffitt & Goodson sold 600 Geron shares in Q3 2022, an estimated $1K.
Proffitt & Goodson first reported a position in Geron in Q2 2022 and held it in 1 quarter.
Proffitt & Goodson's Geron position peaked at $1K in Q2 2022.
179 funds tracked by Wall St. Rank held Geron as of Q3 2022.

Based on Proffitt & Goodson's 13F filing for Q3 2022, filed 24 Oct 2022.